Military Spouse Connection Jobs

Assistant Technician 1 - Formulation Services 1

Req ID: 222199

Location:

Tranent, GB, EH33 2NE

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.

Job Summary

We are seeking an Assistant Technician 1 for our Formulation Services Department located in Elphinstone, Tranent .

Working as an Assistant Technician 1 you’ll join a team responsible for the storage and control of test items and the preparation of formulations supporting toxicology studies.

Duties and responsibilities include:

• Preparation of Vehicles used to prepare formulations

• Preparation of formulations using a variety of techniques

• Delivery of Formulations

• Taking archive and formulation analysis samples

Applicants should have:

• At least an HNC or equivalent in a scientific subject

• A good attention to detail

• IT skills

• Good communication skills

What you can expect from us:

• A clear career progression

• World Class Training and a structured progression scheme

• Pension scheme including 8% employer contribution

• Personal life insurance equivalent to 6 times your annual salary

• Employee discount scheme – discounts across hundreds of retailers!

• Paid opportunity to volunteer for one day each year

• Free onsite fitness suite and fitness lessons

• Discounted staff canteen

• Free onsite parking

The salary for this position is £22,707. In exceptional circumstances where the candidate has relevant equivalent experience, this will be taken into consideration.

The closing date for applications is Monday 20 May 2024.

About Safety Assessment

Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

About Charles River

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 85% of the drugs approved by the FDA in 2019.